Research graph
References from Edoxaban antithrombotic therapy in diabetic patients with atrial fibrillation and stable coronary artery disease: the EPIC-CAD trial. Local targets link to admitted publications; unresolved targets remain external evidence.
Atrial fibrillation and diabetes Mellitus: JACC review topic of the week
10.1016/j.jacc.2019.07.020 · 2019 · External reference
Atrial fibrillation, type 2 diabetes, and non-vitamin K antagonist oral anticoagulants: a review
10.1001/jamacardio.2016.5224 · 2017 · External reference
Impact of diabetes Mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the reduction of atherothrombosis for continued health (REACH) registry
10.1161/circulationaha.114.014796 · 2015 · External reference
Antithrombotic therapy in diabetes: which, when, and for how long?
10.1093/eurheartj/ehab128 · 2021 · External reference
Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective: 2021 update
10.1161/circulationaha.120.050438 · 2021 · External reference
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease
10.1038/s41569-019-0314-y · 2020 · External reference
Role of combination antiplatelet and anticoagulation therapy in diabetes Mellitus and cardiovascular disease: insights from the COMPASS trial
10.1161/circulationaha.120.046448 · 2020 · External reference
Ticagrelor in patients with stable coronary disease and diabetes
10.1056/nejmoa1908077 · 2019 · External reference
Edoxaban antithrombotic therapy for atrial fibrillation and stable coronary artery disease
10.1056/nejmoa2407362 · 2024 · External reference
Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: rationale and design of the randomized EPIC-CAD trial
10.1016/j.ahj.2022.01.014 · 2022 · External reference
Routine functional testing or standard care in high-risk patients after PCI
10.1056/nejmoa2208335 · 2022 · External reference
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
10.1111/j.1538-7836.2005.01204.x · 2005 · External reference
A tutorial on propensity score estimation for multiple treatments using generalized boosted models
10.1002/sim.5753 · 2013 · External reference
Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry
10.1016/j.jacc.2017.07.755 · 2017 · External reference
Antithrombotic therapy for atrial fibrillation with stable coronary disease
10.1056/nejmoa1904143 · 2019 · External reference
Aspirin in patients with chronic coronary syndrome receiving oral anticoagulation
10.1056/nejmoa2507532 · 2025 · External reference
Anticoagulation and antiplatelet therapy for atrial fibrillation and stable coronary disease: meta-analysis of randomized trials
10.1016/j.jacc.2024.12.030 · 2025 · External reference
Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial
10.1136/heartjnl-2025-326646 · 2026 · External reference
Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physician survey-how are we dealing with controversial approaches?
10.1093/europace/euae012 · 2024 · External reference
Analysis of oral anticoagulant dosing and adherence to therapy among patients with nonvalvular atrial fibrillation
10.1001/jamanetworkopen.2023.17156 · 2023 · External reference
Low-dose edoxaban in very elderly patients with atrial fibrillation
10.1056/nejmoa2012883 · 2020 · External reference
Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study
10.1093/europace/euaf230 · 2025 · External reference
2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines
10.1161/cir.0000000000001193 · 2024 · External reference
2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)
10.1093/eurheartj/ehae176 · 2024 · External reference
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
10.1093/europace/euae298 · 2024 · External reference
